A nasal ‘molecular shield’ developed by researchers may soon block mugwort pollen, offering relief from one of the most ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

This could lead to the development of precision allergy treatments that are fast acting, needle free, and tailored to individual allergen sensitivities.

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

After eating a fried risotto ball I started getting a very itchy mouth, blocked sinuses and hives - then, within 30 minutes, ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

Researchers at the Kazakh National Agrarian Research University have developed a pioneering nasal treatment for hay fever ...

Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.